Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2026-06-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 94% confidence The document is a "주식등의 대량보유상황보고서(일반)" filed under the Capital Markets Act, detailing the number and percentage of shares held by a major shareholder and the changes thereto. This matches the "Major Shareholding Notification" category, as it reports large shareholding positions and transactions. Therefore, it should be classified as MRQ.
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a statutory insider ownership report (‘임원ㆍ주요주주 특정증권등 소유상황보고서’) detailing a company director’s and major shareholder’s holdings and transactions in the company’s securities. It lists share counts before and after trades, transaction dates, and methods (e.g., on-market purchases), matching the definition of a Director’s Dealing report (insider trades).
2026-06-05 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” covering the period 2026.01.01–2026.03.31, includes full financial tables (sales by segment, production capacity, risk management, R&D, intellectual property, etc.) and detailed narrative. This is a comprehensive interim/quarterly report, not merely an announcement. It matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed vote outcomes for each agenda item, percentages of votes in favor, and other shareholder meeting particulars. It is not an annual report or meeting materials but specifically the formal announcement of voting results from an AGM. Therefore, it matches the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Jeonjin BioPharm Co., Ltd. for the fiscal year ending December 31, 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR) as it contains the audit opinion and financial statements. FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 97% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and auditor information for the fiscal year 2025. While it contains financial data, it is a standard regulatory disclosure form used to announce the receipt and filing of the audit report, rather than the full audit report document itself. According to the 'Menu vs Meal' rule, this is a regulatory filing announcement. FY 2025
2026-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.